789Wire StoriesPanOptica Announces Licensing Agreement with Zhaoke Ophthalmology for PAN-90806 for the Treatment of Neovascular Eye Diseases in China, South Korea, and Southeast Asia
Zhaoke Ophthalmology has obtained exclusive rights for the development and commercialization of PAN-90806 in Greater China, South Korea, and 10 ASEAN countries...
- 588Wire Stories
FluroTest Diagnostic Systems Featured in Grand View Research Report Exploring Growth of COVID-19 Saliva Screening Test Potential Market
CALGARY, Alberta, June 17, 2021 (GLOBE NEWSWIRE) — FluroTech LTD. (TSXV: TEST) (OTCQB: FLURF) and wholly owned subsidiary FluroTest Diagnostic Systems (“FluroTest”...
- 622Wire Stories
Renesas Unlocks Personalized Air Quality Experiences With Ultra-Low Power ZMOD4510 Outdoor Air Quality Sensor Platform
Enhanced Platform Delivers Selective Ozone Detection, Miniature Sensor, and a IP67 Waterproof Package for Wearables, Smartphones, and Industrial Monitoring Devices TOKYO–(BUSINESS WIRE)–#OAQ–Renesas...
- 729Wire Stories
Radisys Introduces Smart Home Solution to Enhance Service Providers’ Broadband Offerings
Flexible, modular solution helps telcos monetize the smart home HILLSBORO, Ore.–(BUSINESS WIRE)–Radisys® Corporation, a global leader of open telecom solutions, today unveiled...
- 737Wire Stories
Cullgen Announces Prominent Publication by Cullgen Co-Founders Jian Jin and Yue Xiong in Nature Reviews Cancer
SAN DIEGO–(BUSINESS WIRE)–Cullgen Inc., a leading biotechnology company developing small molecule therapeutics based on its proprietary uSMITE™ platform of targeted protein...
- 617Wire Stories
Mi Vacuum Cleaner G9, Another Xiaomi Gadget with Premium Quality at Fair Price
SHENZHEN, China–(BUSINESS WIRE)–#CordlessStickVacuumCleaner–Xiaomi is a smart tech brand known for its vitality and innovation. From best-selling Xiaomi phones to smart TVs, Xiaomi...
- 593Wire Stories
China Ruxolitinib Market Report 2021-2025 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Investigation Report on China’s Ruxolitinib Market 2021-2025” report has been added to ResearchAndMarkets.com’s offering. Ruxolitinib was developed by Novartis Pharma...
- 777Wire Stories
HKTB Debuts Great Outdoors Summer Video Series to Tickle and Titillate the Senses
ASMR videos capture the pleasurable sounds of a sizzling Hong Kong summer HONG KONG–(BUSINESS WIRE)–#DiscoverHongKong–This summer, Hong Kong’s great outdoors will be...
- 697Wire Stories
BeiGene Announces First Patient Dosed in Global Phase 3 Trial of Anti-TIGIT Antibody Ociperlimab in Non-Small Cell Lung Cancer
CAMBRIDGE, Mass. & BEIJING–(BUSINESS WIRE)–$BGNE #BTKi—BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a global biotechnology company focused on developing and commercializing innovative medicines...
- 704Wire Stories
Aerie Pharmaceuticals Completes Enrollment of its first Phase 3 Clinical Trial of Netarsudil Ophthalmic Solution in Japan
Topline results expected in the fourth quarter of 2021 DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), an ophthalmic pharmaceutical company focused on...
